HK1061351A1 - Improved neuronal gene transfer - Google Patents

Improved neuronal gene transfer

Info

Publication number
HK1061351A1
HK1061351A1 HK04102554.0A HK04102554A HK1061351A1 HK 1061351 A1 HK1061351 A1 HK 1061351A1 HK 04102554 A HK04102554 A HK 04102554A HK 1061351 A1 HK1061351 A1 HK 1061351A1
Authority
HK
Hong Kong
Prior art keywords
gene transfer
neuronal gene
improved neuronal
improved
transfer
Prior art date
Application number
HK04102554.0A
Other languages
English (en)
Inventor
Stephanie Millecamps-Navarro
Martine Barkats
Jacques Mallet
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of HK1061351A1 publication Critical patent/HK1061351A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Biotechnology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK04102554.0A 2001-05-22 2004-04-08 Improved neuronal gene transfer HK1061351A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01401342A EP1262188A1 (de) 2001-05-22 2001-05-22 Verbesserter neuronaler Gentransfer
PCT/EP2002/005354 WO2002094308A1 (en) 2001-05-22 2002-05-15 Improved neuronal gene transfer

Publications (1)

Publication Number Publication Date
HK1061351A1 true HK1061351A1 (en) 2004-09-17

Family

ID=8182738

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04102554.0A HK1061351A1 (en) 2001-05-22 2004-04-08 Improved neuronal gene transfer

Country Status (7)

Country Link
US (1) US7341718B2 (de)
EP (2) EP1262188A1 (de)
CA (1) CA2446201C (de)
DE (1) DE60229236D1 (de)
ES (1) ES2314069T3 (de)
HK (1) HK1061351A1 (de)
WO (1) WO2002094308A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201308917D0 (en) 2013-05-17 2013-07-03 Renishaw Plc Delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
DE69121208T2 (de) * 1990-09-25 1997-01-23 Genentech Inc Neuer neurotropischer faktor
WO1995022560A1 (en) * 1994-02-22 1995-08-24 The Syntex-Synergen Neuroscience Joint Venture Pharmaceutical formulations of cntf
US5741778A (en) * 1996-03-19 1998-04-21 Amgen Inc. Method for treating Huntington's disease using glial cell line-derived neurotrophic factor (GDNF) protein product
DE69620888T2 (de) * 1996-11-27 2002-08-14 William J Binder Neurotoxine zur Behandlung von Hauterkrankungen bei Säugetieren
FR2784898A1 (fr) * 1998-10-26 2000-04-28 Univ Pasteur Utilisation du gdnf pour le traitement de la degenerescence retinienne
US6113915A (en) * 1999-10-12 2000-09-05 Allergan Sales, Inc. Methods for treating pain

Also Published As

Publication number Publication date
EP1262188A1 (de) 2002-12-04
US7341718B2 (en) 2008-03-11
CA2446201C (en) 2012-07-17
EP1390059A1 (de) 2004-02-25
CA2446201A1 (en) 2002-11-28
US20040131593A1 (en) 2004-07-08
EP1390059B1 (de) 2008-10-08
ES2314069T3 (es) 2009-03-16
DE60229236D1 (de) 2008-11-20
WO2002094308A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
GB0130616D0 (en) Inter-network transfer
GB0007651D0 (en) Gene sequence
HUP0105208A3 (en) Gene therapy-1
AU6424701A (en) Gasc1 gene
IL146332A0 (en) PrP-LIKE GENE
GB0122232D0 (en) Gene expression
GB0121001D0 (en) Transfer arrangement
EP1428891A4 (de) Nedl-1, ein neues gen
EP1578908A4 (de) Menschliches schizophreniegen
EP1453265A4 (de) Informationstransferverfahren
HK1061351A1 (en) Improved neuronal gene transfer
EP1215284A4 (de) TSG-äHNLICHE GENE
GB0107757D0 (en) Gene regulation II
AU2002338935A1 (en) Improved neuronal gene transfer
GB0104440D0 (en) Novel genes
GB0106786D0 (en) Gene regulation
GB0128769D0 (en) Gene
GB0122730D0 (en) Gene Linkakge
GB0116360D0 (en) Gene PRPC8
EG23081A (en) Segment transfer
GB0109155D0 (en) Gene sequence
GB0125185D0 (en) Gene identification
GB0109008D0 (en) Novel genes
GB0126030D0 (en) Gene expression
GB0109461D0 (en) New Gene

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140515